Cyclic diarylheptanoids inhibit cell-mediated low-density lipoprotein oxidation

Nat Prod Res. 2006 Feb;20(2):139-43. doi: 10.1080/14786410500045895.

Abstract

Two cyclic diarylheptanoids, garugamblin-3 (1) and acerogenin L (2), isolated from the MeOH extract of the fruits of Alnus japonica Steud., inhibited human low-density lipoprotein (LDL) oxidation in the thiobarbituric acid-reactive substance assay with IC50 values of 2.9 and 1.7 microM, respectively, and they also inhibited cell-mediated LDL oxidation more than five times more strongly than that of a well-known antioxidant, probucol, at a concentration of 10 microM. 1 had no effect on the anti-atherogenesis in low-density lipoprotein receptor- deficient mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alnus / chemistry*
  • Animals
  • Antioxidants / pharmacology*
  • Aorta / pathology
  • Atherosclerosis / pathology
  • Diarylheptanoids / chemistry
  • Diarylheptanoids / pharmacology*
  • Female
  • Fruit / chemistry
  • Lipid Peroxidation / drug effects
  • Lipoproteins, LDL / metabolism*
  • Mice
  • Molecular Structure
  • Plant Extracts / pharmacology
  • Thiobarbituric Acid Reactive Substances / analysis

Substances

  • Antioxidants
  • Diarylheptanoids
  • Lipoproteins, LDL
  • Plant Extracts
  • Thiobarbituric Acid Reactive Substances
  • acerogenin L
  • garugamblin-3